Maynard Um
-
-
-
-
-
-
-
Creative Medical receives WHO approval for olastrocel drug name
-
-
-
-
-
-
-
Creative Medical Technology (CELZ) Reports Positive One-Year Results for AlloStem Type 2 Diabetes Program
-
-
-
-
-
-
-
Roth/MKM Reiterates Buy Rating on Creative Medical Tech Holdings Inc. (CELZ)
404,920 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

